• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Valeant Pharmaceuticals International, Inc. (VRX)

    -NYSE
    228.49 Up 0.25(0.11%) Jul 2, 4:01PM EDT
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):3.0
    Mean Recommendation (last week):3.4
    Change:-0.4

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:52.38
    Median Target:50.00
    High Target:75.00
    Low Target:34.50
    No. of Brokers:4

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Feb 9, 2015BarclaysInitiated Overweight
    Oct 30, 2013FBR CapitalInitiated Outperform
    Jun 10, 2013CRT CapitalUpgradeHoldBuy
    Feb 22, 2013Aegis CapitalInitiated Buy
    Feb 5, 2010Jefferies & CoInitiated Buy
    Jul 9, 2009Leerink SwannDowngradeOutperformMkt Perform
    Jun 9, 2009WachoviaDowngradeMkt PerformUnderperform
    May 14, 2009Ladenburg ThalmannInitiated Neutral
    May 14, 2009SoleilInitiated Sell
    Mar 24, 2009Leerink SwannInitiated Outperform

    More Upgrades & Downgrades for VRX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy5566
    Buy12121211
    Hold2221
    Underperform1111
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.